Implementation of a System-level Tobacco Treatment Intervention

Dana-Farber Cancer Institute

Status

Active, not recruiting

Conditions

Lung Cancer

Smoking Cessation

Treatments

Other: Usual Care Tobacco Treatment Services

Other: CEASE

Study type

Interventional

Funder types

Other

Identifiers

NCT02816697

16-208

Details and patient eligibility

About

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

Full description

In particular the study aims to see if participants are asked about their smoking status and what services are offered if someone indicates being a former or current smoker. Findings from this study will help improve a standard of care at this clinic and allow us to understand what type of tobacco treatment services are preferred by patients.

Adaption of CEASE will entail exit interviews with patients and individual interviews with clinical staff to identify and address facilitators and barriers to the implementation process.
Effectiveness of CEASE will be measured through questionnaires & biochemical verification of smoking status using a pre-test/post-test study design before (usual care)and after implementation (CEASE)

Enrollment

263 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age ≥ 18
Have an actual or potential diagnosis of thoracic malignancy
Able to read and write in English.
Current or recent former smoker (defined as having smoked within past 6 months)
Must have an active telephone number.

Exclusion criteria

Former smoker greater than 6 months.
Have any of the below conditions needing immediate medical intervention
- Hypercalcemia causing lethargy and confusion,
- Acute respiratory distress
- Dehydration
- Hypotension

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

263 participants in 5 patient groups

Cease-Aim 1

Active Comparator group

Description:

* Cease Implementation * 100 Patients after CEASE Implementation * Exit Interview and Tobacco Use Survey

Treatment:

Other: CEASE

Pre Cease Implementation Aim 2

Active Comparator group

Description:

50 Current or former smokers (3 months +/-2 month) patients in usual care (before CEASE implementation) * Tobacco Use Survey (Baseline,1- 6 Months) * Biochemical verification

Treatment:

Other: Usual Care Tobacco Treatment Services

After Cease Implementation Aim 2

Experimental group

Description:

50 Current or former smokers (3 months +/-2 month) * Tobacco Use Survey (Baseline,1- 6 Months) * Biochemical verification

Treatment:

Other: CEASE

Usual Care-Aim 1

Active Comparator group

Description:

Usual Care Tobacco Treatment Services * 100 patients in usual care * Exit Interview and Tobacco Use Survey